Vascular progenitor cells and atherosclerosis

Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

Bibliography

• 1  Urbich C, Dimmeler S: Endothelial progenitor cells functional characterization. Trends Cardiovasc. Med.14,318–322 (2004).
  Medline CASGoogle Scholar
• 2  Xu Q: The impact of progenitor cells in atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med.3,94–101 (2006).•• Formed a hypothesis about the role of progenitor cells in the pathogenesis of atherosclerosis.
  Medline CASGoogle Scholar
• 3  Aicher A, Zeiher AM, Dimmeler S: Mobilizing endothelial progenitor cells. Hypertension45,321–325 (2005).
  Medline CASGoogle Scholar
• 4  Aicher A, Rentsch M, Sasaki K et al.: Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res.100,581–589 (2007).• Used an interesting animal model that provided the direct evidence of how tissue progenitors contribute to angiogenesis in other tissues.
  Medline CASGoogle Scholar
• 5  Iwami Y, Masuda H, Asahara T: Endothelial progenitor cells: past, state of the art, and future. J. Cell Mol. Med.8,488–497 (2004).
  MedlineGoogle Scholar
• 6  Case J, Mead LE, Bessler WK et al.: Human CD34⁺AC133⁺VEGFR-2⁺ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol.35,1109–1118 (2007).
  Medline CASGoogle Scholar
• 7  Heissig B, Hattori K, Dias S et al.: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell109,625–637 (2002).
  Medline CASGoogle Scholar
• 8  Jin DK, Shido K, Kopp HG et al.: Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4⁺ hemangiocytes. Nat. Med.12,557–567 (2006).
  Medline CASGoogle Scholar
• 9  Aicher A, Heeschen C, Mildner-Rihm C et al.: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.9,1370–1376 (2003).
  Medline CASGoogle Scholar
• 10  Qin G, Ii M, Silver M et al.: Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J. Exp. Med.203,153–163 (2006).
  Medline CASGoogle Scholar
• 11  Yoshioka T, Takahashi M, Shiba Y et al.: Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc. Res.70,61–69 (2006).
  Medline CASGoogle Scholar
• 12  Ziegelhoeffer T, Fernandez B, Kostin S et al.: Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res.94,230–238 (2004).
  Medline CASGoogle Scholar
• 13  Kang HJ, Kim HS, Zhang SY et al.: Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet363,751–756 (2004).• Demonstrated the positive and negative effects of granulocyte colony-stimulating factor-enhanced endothelial progenitor cell (EPC) mobilization in patients with myocardial infarction.
  Medline CASGoogle Scholar
• 14  Vanderheyden M, Mansour S, Bartunek J: Accelerated atherosclerosis following intracoronary haematopoietic stem cell administration. Heart91,448 (2004).
  Google Scholar
• 15  Assmus B, Walter DH, Lehmann R et al.: Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur. Heart J.27,2989–2995 (2006).
  MedlineGoogle Scholar
• 16  Schachinger V, Erbs S, Elsasser A et al.: Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J.27,2775–2783 (2006).
  MedlineGoogle Scholar
• 17  Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med.9,702–712 (2003).
  Medline CASGoogle Scholar
• 18  Losordo DW, Dimmeler S: Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation109,2692–2697 (2004).
  MedlineGoogle Scholar
• 19  Mallat Z, Silvestre JS, Le Ricousse-Roussanne S et al.: Interleukin 18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ. Res.91,441–448 (2002).
  Medline CASGoogle Scholar
• 20  Hristov M, Zernecke A, Bidzhekov K et al.: Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res.100,590–597 (2007).
  Medline CASGoogle Scholar
• 21  Mayr U, Zou Y, Zhang Z et al.: Accelerated arteriosclerosis of vein grafts in inducible NO synthase^-/- mice is related to decreased endothelial progenitor cell repair. Circ. Res.98,412–420 (2006).• Used intersting mouse model that provided direct evidence for how EPC homing is influenced by nitric oxide and VEGF production.
  Medline CASGoogle Scholar
• 22  Dulak J, Jozkowicz A, Dembinska-Kiec A et al.: Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscl. Thromb. Vasc. Biol.20,659–666 (2000).
  Medline CASGoogle Scholar
• 23  Gershlick AH, Richardson G: Drug eluting stents. Br. Med. J.333,1233–1234 (2006).
  Medline CASGoogle Scholar
• 24  Rotmans JI, Heyligers JM, Verhagen HJ et al.: In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation112,12–18 (2005).
  Medline CASGoogle Scholar
• 25  Xiao Q, Zeng L, Zhang Z et al.: Sca-1⁺ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscl. Thromb. Vasc. Biol.26,2244–2251 (2006).•• First report showing stem cell antigen (Sca)-1+ cells could serve as common progenitors for endothelial and smooth muscle cells.
  Medline CASGoogle Scholar
• 26  Yamamoto K, Takahashi T, Asahara T et al.: Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J. Appl. Physiol.95,2081–2088 (2003).
  MedlineGoogle Scholar
• 27  Zeng L, Xiao Q, Margariti A et al.: HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J. Cell Biol.174,1059–1069 (2006).
  Medline CASGoogle Scholar
• 28  Wassmann S, Werner N, Czech T, Nickenig G: Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ. Res.99,e74–e83 (2006).
  Medline CASGoogle Scholar
• 29  Hill JM, Zalos G, Halcox JP et al.: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med.348,593–600 (2003).
  MedlineGoogle Scholar
• 30  Yoder MC, Mead LE, Prater D et al.: Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood109,1801–1809 (2006).
  MedlineGoogle Scholar
• 31  You D, Waeckel L, Ebrahimian TG et al.: Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation114,328–338 (2006).
  MedlineGoogle Scholar
• 32  Tanaka K, Sata M, Hirata Y, Nagai R: Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ. Res.93,783–790 (2003).
  Medline CASGoogle Scholar
• 33  Werner N, Priller J, Laufs U et al.: Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscl. Thromb. Vasc. Biol.22,1567–1572 (2002).
  Medline CASGoogle Scholar
• 34  Laufs U, Werner N, Link A et al.: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation109,220–226 (2004).
  Medline CASGoogle Scholar
• 35  Sainz J, Al Haj, Zen A et al.: Isolation of “side population” progenitor cells from healthy arteries of adult mice. Arterioscl. Thromb. Vasc. Biol.26,281–286 (2006).
  Medline CASGoogle Scholar
• 36  Abedin M, Tintut Y, Demer LL: Mesenchymal stem cells and the artery wall. Circ. Res.95671–95676 (2004).
  Google Scholar
• 37  Hu Y, Zhang Z, Torsney E et al.: Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J. Clin. Invest.113,1258–1265 (2004).• First report on the presence of vascular progenitors in the adventitial tissue of the vessel wall.
  Medline CASGoogle Scholar
• 38  Fukuda D, Sata M, Tanaka K, Nagai R: Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation111,926–931 (2005).
  Medline CASGoogle Scholar
• 39  Schober A, Karshovska E, Zernecke A, Weber C: SDF-1α-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc. Med.16,103–108 (2006).
  Medline CASGoogle Scholar
• 40  Zernecke A, Schober A, Bot I et al.: SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res.96,784–791 (2005).
  Medline CASGoogle Scholar
• 41  Abbott JD, Huang Y, Liu D et al.: Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation110,3300–3305 (2004).
  MedlineGoogle Scholar
• 42  Askari AT, Unzek S, Popovic ZB et al.: Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet362,697–703 (2003).
  Medline CASGoogle Scholar
• 43  Shimizu K, Sugiyama S, Aikawa M et al.: Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat. Med.7,738–741 (2001).
  Medline CASGoogle Scholar
• 44  Saiura A, Sata M, Hirata Y et al.: Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med.7,382–383 (2001).
  Medline CASGoogle Scholar
• 45  Han CI, Campbell GR, Campbell JH: Circulating bone marrow cells can contribute to neointimal formation. J. Vasc. Res.38,113–119 (2001).
  Medline CASGoogle Scholar
• 46  Hillebrands JL, Klatter FA, van den Hurk BM et al.: Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J. Clin. Invest.107,1411–1422 (2001).
  Medline CASGoogle Scholar
• 47  Li J, Han X, Jiang J et al.: Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am. J. Pathol.158,1943–1947 (2001).
  Medline CASGoogle Scholar
• 48  Sata M, Saiura A, Kunisato A et al.: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med.8,403–409 (2002).• Demonstrated that more than 50% of smooth muscle cells in atherosclerotic lesions are derived from bone marrow stem cells.
  Medline CASGoogle Scholar
• 49  Hu Y, Davison F, Ludewig B et al.: Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation106,1834–1839 (2002).• Report demonstrated non-bone marrow origin of smooth muscle cells in arteriosclerotic lesions.
  MedlineGoogle Scholar
• 50  Hu Y, Mayr M, Metzler B et al.: Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ. Res.91,e13–e20 (2003).
  Google Scholar
• 51  Simper D, Stalboerger PG, Panetta CJ et al.: Smooth muscle progenitor cells in human blood. Circulation106,1199–1204 (2002).
  Medline CASGoogle Scholar
• 52  Frid MG, Kale VA, Stenmark KR: Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ. Res.90,1189–1196 (2002).
  Medline CASGoogle Scholar
• 53  Tintut Y, Alfonso Z, Saini T et al.: Multilineage potential of cells from the artery wall. Circulation108,2505–2510 (2003).
  MedlineGoogle Scholar
• 54  Zhang L, Freedman NJ, Brian L, Peppel K: Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler. Thromb. Vasc. Biol.24,470–476 (2004).
  MedlineGoogle Scholar
• 55  Prunet-Marcassus B, Cousin B, Caton D et al.: From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp. Cell Res.312,727–736 (2006).
  Medline CASGoogle Scholar
• 56  Miranville A, Heeschen C, Sengenes C et al.: Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation110,349–355 (2004).
  Medline CASGoogle Scholar
• 57  Planat-Benard V, Silvestre JS, Cousin B et al.: Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation109,656–663 (2004).
  MedlineGoogle Scholar
• 58  Rehman J, Traktuev D, Li J et al.: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation109,1292–1298 (2004).
  MedlineGoogle Scholar
• 59  Vasa M, Fichtlscherer S, Adler K et al.: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation103,2885–2890 (2001).
  Medline CASGoogle Scholar
• 60  Walter DH, Rittig K, Bahlmann FH et al.: Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation105,3017–3024 (2002).
  Medline CASGoogle Scholar
• 61  Werner N, Junk S, Laufs U et al.: Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res.93,e17–e24 (2003).
  Medline CASGoogle Scholar
• 62  Bompais H, Chagraoui J, Canron X et al.: Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood103,2577–2584 (2004).
  Medline CASGoogle Scholar